| --- | --- | --- | --- | |---------------------------------------------|-------|-------|-------| | | | | | | Clinical antifibrotic effect of Aramchol™: | | | | Prof. Vlad Ratziu, Professor of Hepatology, Sorbonne Université, ARMOR study coprincipal investigator November 2021 1 Safe Harbor and Disclaimer Statement This presentation contains forward-looking statements about our expectations, beliefs or intentions regarding, among other things, our product development efforts, business, financial condition, r ...

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Q3 2021 Earnings Conference Call November 8, 2021 8:30 AM ET Company Participants Allen Baharaff - President and Chief Executive Officer Yohai Stenzler - Chief Financial Officer Liat Hayardeny - Chief Scientific Officer Vlad Ratziu - Professor, Hepatology, Sorbonne Université Conference Call Participants Ryan Deschner - Raymond James Thomas Yip - H.C. Wainwright Justin Zelin - BTIG Operator Good day and welcome to the Galmed Conference Call to discuss Financial Resu ...

| --- | --- | --- | --- | |---------------------------------------------|-------|-------|-------| | | | | | | Clinical antifibrotic effect of Aramchol™: | | | | Prof. Vlad Ratziu, Professor of Hepatology, Sorbonne Université, ARMOR study coprincipal investigator November 2021 1 Safe Harbor and Disclaimer Statement This presentation contains forward-looking statements about our expectations, beliefs or intentions regarding, among other things, our product development efforts, business, financial condition, r ...

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Q2 2021 Results Earnings Conference Call August 5, 2021 8:30 AM ET Company Participants Allen Baharaff - President, Chief Executive Officer Yohai Stenzler - Chief Financial Officer Liat Hayardeny - Chief Scientific Officer Conference Call Participants Edward Nash - Canaccord Genuity Kristen Kluska - Cantor Fitzgerald Timur Ivannikov - Raymond James Operator Good day and welcome to Galmed conference call to discuss financial results for the second quarter 2021. Today ...

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Q1 2021 Earnings Conference Call May 13, 2021 8:30 AM ET Company Participants Allen Baharaff - President & Chief Executive Officer Liat Hayardeny - Chief Scientific Officer Yohai Stenzler - Chief Financial Officer Conference Call Participants Steve Seedhouse - Raymond James Thomas - H.C. Wainwright Rick - Cantor Fitzgerald Operator Good day. Welcome to the Galmed Conference Call to discuss Financial Results for the First Quarter 2021. Today's conference is being rec ...

Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of ...

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Q4 2020 Earnings Conference Call March 18, 2021 8:30 AM ET Company Participants Allen Baharaff - President & Chief Executive Officer Yohai Stenzler - Chief Financial Officer Conference Call Participants Ed Arce - H.C. Wainwright Steve Seedhouse - Raymond James Kristen Kluska - Cantor Fitzgerald Operator Good day. Welcome to the Galmed Conference Call to discuss Financial Results for the Fourth Quarter and Year Ended 2020. Today's conference is being recorded. Before ...

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Q3 2020 Earnings Conference Call November 12, 2020 8:30 AM ET Company Participants Allen Baharaff - President & Chief Executive Officer Yohai Stenzler - Chief Financial Officer Dr. Liat Hayardeny - Chief Scientific Officer Conference Call Participants Steve Seedhouse - Raymond James Kristen Kluska - Cantor Fitzgerald Ed Arce - H.C. Wainwright Operator Good day, and welcome to the Galmed Conference Call to discuss financial results for the third quarter of 2020. Toda ...

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Q2 2020 Results Conference Call August 6, 2020 8:30 AM ET Company Participants Allen Baharaff - President and CEO Dr. Tali Gorfine - CMO Yohai Stenzler - CFO Dr. Liat Hayardeny - CSO Conference Call Participants Steve Seedhouse - Raymond James Ed Arce - H.C. Wainwright Kristen Kluska - Cantor Fitzgerald Operator Good day, and welcome to the Galmed conference call to discuss Financial Results for the Second Quarter of 2020. TodayÂ's conference is being recorded. Befo ...

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Q1 2020 Earnings Conference Call May 14, 2020 8:30 AM ET Company Participants Allen Baharaff - Chairman, CEO & President Yohai Stenzler - CFO & Controller Liat Hayardeny - Chief Scientific Officer Tali Gorfine - Chief Medical Officer Conference Call Participants Steve Seedhouse - Raymond James Adam Walsh - Stifel Kristen Kluska - Cantor Fitzgerald Ed Arce - H.C. Wainwright Mayank Mamtani - B. Riley FBR, Inc. Operator Good day. Welcome to GalmedÂ's Conference Call to ...